- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06613347
Clinical Study to Assess the Efficacy of Professional Tooth Whitening Maintenance System
May 20, 2025 updated by: Colgate Palmolive
Clinical Study to Assess the Efficacy of Professional Tooth Whitening Maintenance System of a Colgate Regimen
Clinical study to assess the efficacy of professional tooth whitening maintenance system of a Colgate toothpaste containing 5% Hydrogen Peroxide with a stain-fighter mouthwash as compared to only the stainfighter mouthwash and a negative control toothpaste
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
93
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Costa Mesa, California, United States, 92627
- FAR Oral and Systemic Health Consulting, Inc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- permanent natural teeth (6-11) (22-27)
- composite lobene =>1
- Signed Informed Consent Form
- Male and female subjects aged 18-70 years, inclusive
- Good general health and good oral health based on the opinion of the study investigator
- All maxillary anterior teeth (teeth #6 through #11) must be present;& mandibular anterior ( Teeth #22 through 27) must be present
- Availability for the duration of the study
- Minimum average Vita Extended Bleachedguide 3D-Master shade score of 17 ≥ or darker
- A minimum mean of 1.5 ≥ determined by the Interproximal Modified Lobene (IML) Stain Index
- Demonstrate a tendency to form stain in anterior teeth/ Have high staining habits ( coffee/ wine/ tea drinker)
Exclusion Criteria:
- allergies
- Presence of orthodontic appliances or any anterior tooth with a prosthetic crown or veneer
- Restorations on the tooth to be scored which may interfere with scoring procedures
- Obvious signs of periodontal disease, rampant caries, or any condition that the dental examiner considers exclusionary from the study
- Five or more carious lesions requiring immediate care
- Concurrent participation in another clinical study
- Self-reported pregnant and/or lactating women
- History of allergies to tooth whitening products, hydrogen peroxide, personal care consumer products, or their ingredients
- Have dentinal sensitivity
- Taking medication within a year which could alters natural tooth color or appearance,
- Have used Professional Whitening product within a year or had a dental prophylaxis ( professional dental cleaning) within 30 days prior to the start of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Negative Control
|
negative control
|
|
Experimental: Whitening Regimen
|
whitening maintenance regimen
Other Names:
|
|
Active Comparator: Whitening MW
|
maintenance MW
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tooth color assessment
Time Frame: Baseline
|
Changes in Tooth color determined by examiner use of Vita Extended Bleachedguide 3D-Master®(29 tabs)
|
Baseline
|
|
Tooth color assessment
Time Frame: 4 weeks
|
Changes in Tooth color determined by examiner use of Vita Extended Bleachedguide 3D-Master®(29 tabs)
|
4 weeks
|
|
Tooth color assessment
Time Frame: 8 weeks
|
Changes in Tooth color determined by examiner use of Vita Extended Bleachedguide 3D-Master®(29 tabs)
|
8 weeks
|
|
Interproximal Modified Lobene Stain Index
Time Frame: Baseline
|
Stain examination will be determined by the Interproximal Modified Lobene(IML) Stain Index
|
Baseline
|
|
Interproximal Modified Lobene Stain Index
Time Frame: 4 week
|
Stain examination will be determined by the Interproximal Modified Lobene(IML) Stain Index
|
4 week
|
|
Interproximal Modified Lobene Stain Index
Time Frame: 8 week
|
Stain examination will be determined by the Interproximal Modified Lobene(IML) Stain Index
|
8 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2024
Primary Completion (Actual)
December 15, 2024
Study Completion (Actual)
December 20, 2024
Study Registration Dates
First Submitted
September 20, 2024
First Submitted That Met QC Criteria
September 23, 2024
First Posted (Actual)
September 25, 2024
Study Record Updates
Last Update Posted (Actual)
May 21, 2025
Last Update Submitted That Met QC Criteria
May 20, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CRO-2024-07-WHT- SPMW-BGS_ MH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
It will report only results as aggregate
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Staining
-
Abbott Medical OpticsCompletedCorneal StainingUnited States
-
CooperVision, Inc.CompletedCorneal StainingUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedConjunctival StainingUnited States
-
Alcon ResearchCompletedConjunctival StainingUnited States
-
Innovative MedicalCompletedCorneal StainingUnited States
-
Innovative MedicalCompletedCorneal StainingUnited States
-
dott. Lorenzo BevilacquaCompletedStaining Effect of ChlorhexidineItaly
-
Andrasko, Gary, OD, LLCAlcon ResearchUnknownCorneal Staining | Corneal Epithelial DisruptionUnited States
-
University of PaviaCompletedExtrinsic Staining of Tooth - MedicationItaly
Clinical Trials on whitening maintenance
-
University of ZagrebUnknown
-
Cairo UniversityBritish University In EgyptCompleted
-
Tufts UniversityCompletedXerostomiaUnited States
-
Glo Science, Inc.Arizona School of Dentistry & Oral Health, A. T. Still UniversityCompleted
-
Universidad Rey Juan CarlosCompletedTeeth Whitening | Dental HypersensitivitySpain
-
Daniela Kovacevic PavicicUniversity of RijekaCompletedQuality of Life | Tooth DiscolorationCroatia
-
Tufts UniversityActive, not recruitingXerostomia | HalitosisUnited States
-
National Taiwan University HospitalL'OrealUnknown
-
Universidad Rey Juan CarlosAlign Technology, Inc.CompletedGingivitis | Satisfaction, Patient | Tooth Discoloration | Tooth SensitivitySpain
-
Lacer S.A.Not yet recruiting